BioNano Genomics Nachrichten und Aktivitäten
Präsenz
BioNano Genomics ist ein Unternehmen, das unter dem Börsenticker BNGO (US) gelistet ist.
Führungskräfte
Siehe das Organigramm mit seine 20 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei BioNano Genomics
- Erik Holmlin, Director, President and Chief Executive Officer
- Kristiina Vuori, Director
- Vincent Wong, Director
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von BioNano Genomics nachzuverfolgen.
Biotechnologie
BioNano Genomics hat 2.350 Konkurrenten , einschließlich Eurofins (Luxemburg), Lonza (Schweiz) und Genus (Großbritannien).
Popular M&A news in Biotechnologie
- Transcarent and Accolade have merged (veröffentlicht am 9, April 2025)..
- Kashiv BioSciences hat gerade eine Spendenaktion von 150 Millionen Dollar angekündigt. (veröffentlicht am 7, April 2025).
- Atsena Therapeutics hat gerade eine Spendenaktion von 150 Millionen Dollar angekündigt. (veröffentlicht am 4, April 2025).
Andere vorgeschlagene Kontakte der Biotechnologie branche
Nachrichten
Neueste Pressemitteilungen nach BioNano Genomics
- Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
- Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
- Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
- Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
- Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
- Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
- Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
- Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
- Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
- Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
- View more press releases Close
Social media about BioNano Genomics
- BioNano Genomics auf Wikipedia, Google News & Yahoo Finance
- BioNano Genomics auf LinkedIn, Twitter & YouTube
